What markers track peripheral nerve regeneration?

Peripheral nerve regeneration is tracked not by a single marker but by a panel of readouts that fall into four families: functional recovery scores, electrophysiological measures, histological and morphometric indices, and molecular or protein markers of axonal growth and Schwann cell activity. In the animal and in vitro literature, the most commonly reported endpoints include the sciatic functional index (SFI), compound muscle action potential (CMAP) amplitude and nerve conduction velocity, axon count and myelin thickness from histology, and expression of growth-associated proteins such as FGF-2 and its receptor family. No single marker is sufficient; studies typically combine at least one functional measure with one histological or electrophysiological measure to avoid over-interpreting any one readout.

The pathway most central to the work surveyed here is fibroblast growth factor (FGF) signalling, particularly FGF-2 acting through FGFR-family receptor tyrosine kinases, which is studied alongside the broader neurotrophic and extracellular-matrix signalling environment that Schwann cells and regenerating axons depend on.

Research Studies

FGF-2 and controlled release from GelMA/Laponite nerve wraps

A biofunctional nanocomposite nerve interface combining an ion-covalent gelatin methacryloyl (GelMA)/Laponite hydrogel with engineered thermostable FGF-2 was developed to recreate a regenerative microenvironment after peripheral nerve transection [1]. Laponite incorporation at 2%–2.5% w/v modulated the hydrogel network, producing shear-thinning behaviour, enhanced viscoelasticity, microporosity, a twofold increase in compressive modulus, controlled degradation, injectability and 3D bioprintability [1]. Functionalisation with thermostable FGF-2 enabled sustained release, and the construct was evaluated as a 3D-printed nerve wrap interface [1]. In this work, FGF-2 release kinetics and the resulting functional regeneration were the tracked markers, linking a molecular payload to a functional outcome in the animal model used.

Bone-derived conduits and functional recovery in rat sciatic gap models

Decalcified and decellularised bone conduits were compared as nerve guidance conduits (NGCs) for bridging peripheral nerve injuries, a setting where gaps exceeding 5 mm do not regenerate spontaneously [2]. Conduits fabricated from rat femoral diaphysis and chicken ulna were characterised for collagen preservation, luminal geometry, and mechanical and electrical properties, then implanted to bridge 10 mm sciatic nerve gaps in rats [2]. Functional recovery was assessed over 16 weeks [2]. This study illustrates the standard marker set for conduit research: scaffold characterisation before implantation, followed by longitudinal functional scoring in vivo.

Sciatic functional index as a behavioural marker

The sciatic functional index (SFI) is a walking-track-derived score widely used to track functional recovery after sciatic nerve injury in rodents. In the bone-conduit comparison, functional recovery was followed over 16 weeks using such scoring [2]. SFI is a behavioural marker: it reflects integrated motor function rather than a single cellular process, and it is typically reported alongside histological or electrophysiological data rather than in isolation.

Electrophysiological markers: CMAP and conduction velocity

Electrophysiological readouts, including compound muscle action potential (CMAP) amplitude and nerve conduction velocity, are used to quantify reinnervation of target muscle. These measures appear in the conduit literature as part of the functional assessment battery [2]. They are attractive because they are quantitative and can be repeated longitudinally, but they require careful electrode placement and temperature control to be comparable across animals and studies.

Histological and morphometric markers of axonal regeneration

Histological endpoints include axon count, axon diameter, myelin thickness and g-ratio, typically obtained from semi-thin or toluidine-blue-stained sections distal to the injury site. In the bone-conduit study, conduits were characterised for collagen preservation and luminal geometry before implantation, and histological assessment formed part of the in vivo evaluation [2]. These morphometric markers describe the structural substrate of regeneration but do not by themselves demonstrate functional recovery.

Scaffold properties as surrogate markers in conduit research

In nerve guidance conduit work, material properties are often treated as surrogate markers of regenerative potential. The bone-conduit comparison characterised mechanical and electrical properties alongside collagen preservation and luminal geometry [2]. In the GelMA/Laponite system, compressive modulus, degradation profile, injectability and bioprintability were quantified as design parameters before biological evaluation [1]. These are in vitro or ex vivo markers; they indicate whether a construct is likely to be handleable and stable, not whether it will regenerate nerve.

Molecular markers of the regenerative microenvironment

FGF-2 is a molecular marker and an active agent in the GelMA/Laponite nerve wrap work, where sustained release from the hydrogel was engineered to recreate a regenerative microenvironment [1]. Molecular markers in this field generally fall into categories: neurotrophic factors and their receptors, growth-associated proteins, and extracellular matrix components. Their measurement is usually performed in vitro or in animal tissue, and their relationship to human functional recovery is not established by these studies.

Comparative marker summary

Where the evidence is animal-only or in vitro

The GelMA/Laponite FGF-2 nerve wrap work is a preclinical nanocomposite study; its release, mechanical and bioprinting data are in vitro or ex vivo, and its functional regeneration data come from the animal model used in that study [1]. The bone-conduit comparison is explicitly an in vivo rat study, with conduits implanted into 10 mm sciatic nerve gaps and followed for 16 weeks [2]. Neither body of work establishes human dosing, human efficacy, or a validated human marker panel. Reference material in this area also discusses combined neuromodulatory approaches, but such hypotheses are not substitutes for controlled marker data [3].

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only, and we do not provide dosing, medical guidance or treatment recommendations. Anyone considering a compound for themselves should speak to a licensed clinician. Nothing on this page should be used to self-treat a nerve injury.

Sources

• [1] Laponite Network Controls FGF-2 Release and Drives Functional Nerve Regeneration via 3D-Printed Nerve Wrap Interfaces. https://pubmed.ncbi.nlm.nih.gov/42695428/
• [2] Decalcified and Decellularized Bone Conduits for Peripheral Nerve Regeneration: A Comparative In Vivo Study Using Rat Femur and Chicken Ulna Conduits. https://europepmc.org/article/PMC/PMC13544568
• [3] Peripheral nerve regeneration and synergistic pharmacology using Hericium erinaceus, lithium, and vitamin B12: The triple neuromodulatory axis hypothesis. https://pubmed.ncbi.nlm.nih.gov/41878942/